Alec Kacew

720 total citations
25 papers, 400 citations indexed

About

Alec Kacew is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Alec Kacew has authored 25 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Otorhinolaryngology and 4 papers in Surgery. Recurrent topics in Alec Kacew's work include Head and Neck Cancer Studies (6 papers), Economic and Financial Impacts of Cancer (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Alec Kacew is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Economic and Financial Impacts of Cancer (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Alec Kacew collaborates with scholars based in United States, Germany and India. Alec Kacew's co-authors include Randy F. Sweis, Glenn J. Hanna, Jochen H. Lorch, Garth W. Strohbehn, Robert I. Haddad, Ethan Harris, Peter S. Hammerman, Alessandro Villa, Nicole G. Chau and Jennifer Frustino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Alec Kacew

25 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alec Kacew United States 12 157 99 76 75 63 25 400
Hélio Humberto Angotti Carrara Brazil 14 188 1.2× 158 1.6× 57 0.8× 73 1.0× 11 0.2× 53 544
Federica Corso Italy 12 133 0.8× 116 1.2× 50 0.7× 19 0.3× 16 0.3× 24 451
Qinjing Pan China 15 202 1.3× 130 1.3× 373 4.9× 31 0.4× 35 0.6× 71 813
Megan Eguchi United States 11 189 1.2× 93 0.9× 97 1.3× 26 0.3× 4 0.1× 37 402
Richa Chauhan India 9 61 0.4× 50 0.5× 30 0.4× 13 0.2× 18 0.3× 53 293
Mary T. Galgano United States 12 138 0.9× 141 1.4× 272 3.6× 32 0.4× 44 0.7× 14 752
Yuqin Song China 10 162 1.0× 87 0.9× 46 0.6× 59 0.8× 15 0.2× 66 371
Eva Sigstad Norway 14 86 0.5× 37 0.4× 237 3.1× 24 0.3× 261 4.1× 21 508
Devasena Anantharaman France 15 176 1.1× 295 3.0× 162 2.1× 43 0.6× 4 0.1× 31 814
Tobias Wiedemann Germany 10 46 0.3× 103 1.0× 251 3.3× 109 1.5× 65 1.0× 23 442

Countries citing papers authored by Alec Kacew

Since Specialization
Citations

This map shows the geographic impact of Alec Kacew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alec Kacew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alec Kacew more than expected).

Fields of papers citing papers by Alec Kacew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alec Kacew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alec Kacew. The network helps show where Alec Kacew may publish in the future.

Co-authorship network of co-authors of Alec Kacew

This figure shows the co-authorship network connecting the top 25 collaborators of Alec Kacew. A scholar is included among the top collaborators of Alec Kacew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alec Kacew. Alec Kacew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dennis, Michael J., Dean C. Pavlick, Alec Kacew, et al.. (2024). Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma. Journal of Translational Medicine. 22(1). 960–960. 2 indexed citations
2.
Kacew, Alec, et al.. (2023). Systemic and Targeted Therapies in Adenoid Cystic Carcinoma. Current Treatment Options in Oncology. 24(1). 45–60. 12 indexed citations
3.
Kacew, Alec, et al.. (2023). The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy. Current Oncology Reports. 25(3). 189–199. 58 indexed citations
4.
Kacew, Alec, et al.. (2022). Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings. npj Breast Cancer. 8(1). 32–32. 12 indexed citations
5.
Strohbehn, Garth W., Alec Kacew, Daniel A. Goldstein, Robin Feldman, & Mark J. Ratain. (2021). Combination therapy patents: a new front in evergreening. Nature Biotechnology. 39(12). 1504–1510. 9 indexed citations
6.
Kacew, Alec, Anand Patel, Fay J. Hlubocky, et al.. (2021). Provider-Level Barriers to Human Papillomavirus Vaccination in Survivors of Childhood and Young Adult Cancers. Journal of Adolescent and Young Adult Oncology. 11(3). 284–289. 7 indexed citations
7.
Richard, Guilhem, Anne S. De Groot, Gary D. Steinberg, et al.. (2021). Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival. Scientific Reports. 11(1). 9983–9983. 6 indexed citations
8.
Kacew, Alec & Glenn J. Hanna. (2021). Value and Unmet Needs in Non-Invasive Human Papillomavirus (HPV) Testing for Oropharyngeal Cancer. Cancers. 13(3). 562–562. 4 indexed citations
9.
Kacew, Alec & Randy F. Sweis. (2020). FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer. Frontiers in Immunology. 11. 575258–575258. 51 indexed citations
10.
Hanna, Glenn J., Alec Kacew, H. Grote, et al.. (2020). Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma. Frontiers in Medicine. 7. 198–198. 5 indexed citations
11.
Kacew, Alec, Ethan Harris, Jochen H. Lorch, et al.. (2020). Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck. Oral Oncology. 105. 104676–104676. 16 indexed citations
12.
Kacew, Alec, Gabriel J. Starrett, Manisha Thakuria, et al.. (2020). 306 Predictors of immunotherapy benefit in Merkel cell carcinoma. SHILAP Revista de lepidopterología. A188.1–A188. 1 indexed citations
13.
Harris, Ethan, Alarice Lowe, Nicole G. Chau, et al.. (2020). Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck. Laryngoscope Investigative Otolaryngology. 5(6). 1063–1069. 8 indexed citations
14.
Harris, Ethan, Glenn J. Hanna, Nicole G. Chau, et al.. (2019). Everolimus in Anaplastic Thyroid Cancer: A Case Series. Frontiers in Oncology. 9. 106–106. 25 indexed citations
15.
Kacew, Alec, Ethan Harris, Jochen H. Lorch, et al.. (2019). Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma. European Journal of Cancer. 113. 1–9. 20 indexed citations
16.
Villa, Alessandro, Glenn J. Hanna, Alec Kacew, et al.. (2019). Oral keratosis of unknown significance shares genomic overlap with oral dysplasia. Oral Diseases. 25(7). 1707–1714. 43 indexed citations
17.
Kacew, Alec, Ethan Harris, Glenn J. Hanna, et al.. (2019). Impact of dental insurance coverage on presentation, long-term outcomes, and symptom burden in locally advanced head and neck cancer.. Journal of Clinical Oncology. 37(15_suppl). e18230–e18230. 1 indexed citations
18.
Lorch, Jochen H., Roy B. Tishler, Nicole G. Chau, et al.. (2018). A phase I study of the PI3K inhibitor buplarlisib (B) with concurrent chemoradiotherapy (CRT) in patients with high risk locally advanced squamous cell cancer of the head and neck (LASCCHN).. Journal of Clinical Oncology. 36(15_suppl). 6071–6071. 5 indexed citations
19.
Hanna, Glenn J., Alec Kacew, Nicole G. Chau, et al.. (2018). Improved outcomes in PI3K-pathway-altered metastatic HPV oropharyngeal cancer. JCI Insight. 3(17). 22 indexed citations
20.
Harris, Ethan, Glenn J. Hanna, Nicole G. Chau, et al.. (2018). Everolimus in anaplastic thyroid cancer: A case series.. Journal of Clinical Oncology. 36(15_suppl). e18112–e18112. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélio Humberto Angotti Carrara Breakdown of academic impact, for papers by Federica Corso Breakdown of academic impact, for papers by Qinjing Pan Breakdown of academic impact, for papers by Megan Eguchi Breakdown of academic impact, for papers by Richa Chauhan Breakdown of academic impact, for papers by Mary T. Galgano Breakdown of academic impact, for papers by Yuqin Song Breakdown of academic impact, for papers by Eva Sigstad Breakdown of academic impact, for papers by Devasena Anantharaman Breakdown of academic impact, for papers by Tobias Wiedemann
Rankless by CCL
2026